GRAY MARY ANN
SEC insider (Form 3/4/5 filer). CIK 0001261974. Director at Keros Therapeutics, Inc. (KROS) and 3 other issuers. 22 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in LEXINGTON, MA.
Companies GRAY MARY ANN has filed insider reports for
- Keros Therapeutics, Inc. (KROS): Director
- RAPT Therapeutics, Inc. (RAPT): Director
- Compass Therapeutics, Inc. (CMPX): Director
- BioAtla, Inc. (BCAB): Director
GRAY MARY ANN
CIK: 0001261974
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 3, 2026KROS
Keros Therapeutics, Inc.
AwardDirect7.1K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
484 shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
Tender OfferDirect5K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
938 shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
1.1K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
478 shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
2.8K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
498 shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
938 shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
560 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  KROS Keros Therapeutics, Inc. | Award | 7,142 | - | $0 | Direct |
| Mar 3, 2026 |  RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 484 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Tender Offer | 4,956 | - | $0 | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 938 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 1,063 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 478 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 2,813 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 498 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 938 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 560 | - | - | Direct |
1-10 of 22 transactions